Centrexion Therapeutics Corporation Registered Shs Aktie
ISIN: US15643W1009
13.01.2025 15:54:17
|
Context Therapeutics Appoints Andy Pasternak As Board Chairman
(RTTNews) - Context Therapeutics Inc. (CNTX), a biopharmaceutical company, Monday announced, that it has appointed Andy Pasternak as Chairman of its Board of Directors. Pasternak succeeds Richard Berman, who stepped down from the Board on January 12.
Pasternak has most recently served as Executive Vice President and Chief Strategy Officer at Horizon Therapeutics, a biotechnology company specializing in therapies for serious and rare autoimmune diseases.
CNTX is currently trading at $1.05, down 2.78 percent or $0.03 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Centrexion Therapeutics Corporation Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |